In last trading session, RAPT Therapeutics Inc (NASDAQ:RAPT) saw 0.42 million shares changing hands with its beta currently measuring 0.52. Company’s recent per share price level of $8.33 trading at $0.21 or 2.52% at ring of the bell on the day assigns it a market valuation of $289.88M. That closing price of RAPT’s stock is at a discount of -228.33% from its 52-week high price of $27.35 and is indicating a premium of 17.65% from its 52-week low price of $6.86. Taking a look at company’s average trading volume volume of 1.40 million if we extend that period to 3-months.

RAPT Therapeutics Inc (NASDAQ:RAPT) trade information

Upright in the green during last session for gaining 2.52%, in the last five days RAPT remained trading in the green while hitting it’s week-highest on Friday, 05/03/24 when the stock touched $8.33 price level, adding 2.91% to its value on the day. RAPT Therapeutics Inc’s shares saw a change of -66.48% in year-to-date performance and have moved 2.84% in past 5-day. RAPT Therapeutics Inc (NASDAQ:RAPT) showed a performance of 4.00% in past 30-days.

RAPT Therapeutics Inc (RAPT) estimates and forecasts

Statistics highlight that RAPT Therapeutics Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company lost -41.46% of value to its shares in past 6 months, showing an annual growth rate of -4.59% while that of industry is 12.80. Apart from that, the company came lowering its revenue forecast for fiscal year 2024.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -12.39% during past 5 years.

RAPT Dividends

RAPT Therapeutics Inc is more likely to be releasing its next quarterly report in June and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.